Social Sentiment for ACAD
Bullish vs. Bearish opinions
Weighted Sentiment 0.00
ACADIA Pharmaceuticals Inc. Forecast and Stock Analysis
Technical ACAD stock analysis for Thursday May 23, 2019.
|Price to book||USD 8.66|
|Next Earnings Date||2019-08-04|
ACADIA Pharmaceuticals Inc. gained 0.80% in the last trading day ( Thursday, 23rd May 2019 ), rising from $25.14 to $25.34 During day the stock fluctuated 5.70% from a day low at $24.03 to a day high of $25.40. The price has fallen in 6 of the last 10 days and is down by -2.46% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.48 million more shares were traded than the day before. In total, 1.05 million shares bought and sold for approximately $26.71 million.
- 30 day high of the ACAD stock price was $26.86 and low was $23.19.
- 90 day high was $28.67 and low was $22.13.
- 52 week high for the ACADIA Pharmaceuticals Inc. - $28.67 and low - $12.77.
ACADIA Pharmaceuticals Inc. lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.27% during the next 3 months and, with 90% probability hold a price between $21.85 and $26.29 at the end of this period.
A buy signal was issued from a pivot bottom point on Wednesday May 22, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. ACADIA Pharmaceuticals Inc. holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $25.41. On a fall, the stock will find some support from the short-term average at $25.27. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.
Relative Strength Index (RSI)
RSI14 is 43 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $23.58 and $23.56.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ACADIA Pharmaceuticals Inc. finds support just below today's level at $23.58. If this is broken, then the next support from accumulated volume will be at $23.56 and $23.32.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.37 (5.70%) between high and low. For the last week, the stock has had a daily average volatility of 3.97%.
Our recommended stoploss: $23.76 (-6.23%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
3.97 %Average volatility
Very Low Low Medium High Very High
ACADIA Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ACAD $25.34 ($0.20 0.80%)|
ACAD is up $0.20 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ACAD based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ACAD analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us